Termine & Events: 2011-10-31Innovacell presents at congress in London Innovacell Biotechnologie AG today has announced to be one of the presenters at the upcoming Commercial Translation of Regenerative Medicine Congress in London from November 14th - 16th. read more »

Termine & Events: 2011-10-10Innovacell presents at Bio-Europe Congress in Düsseldorf Innovacell Biotechnologie AG today announced to be one of the presenters at the upcoming Bio-Europe Congress in Düsseldorf, Germany from October 31st - November 2nd. read more »

Press release: 2011-08-30Innovacell passes a further milestone Phase IIb study of cell therapy for the treatment of stress urinary incontinence concludes successfully - Phase III study to begin later this year, first results expected in third quarter of 2012 - EU approval to be sought in 2013. read more »

Press release: 2011-02-22Innovacell makes further progress on product development The monocomponent preparations, ICES13 and ICEF15 - cell therapies for the treatment of stress urinary incontinence and faecal incontinence - are currently undergoing development in clinical studies and should emerge onto the market in 2013/2015. read more »

Press release: 2010-10-06Fresh injection of capital for Innovacell Shareholders make 4.3 million euros available - financing thus secured for current multi-centre Phase IIb study - clinical testing of urocell^® should be finalised by the end of 2010 read more »

Press release: 2010-06-09Innovacell includes first patients in study for urocell^® A total of 245 patients will be treated during Phase IIb - the study will evaluate the effectiveness and determine the optimal dose for treatment. read more »